Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) Operating Expenses (2020 - 2026)

Lucid Diagnostics filings provide 5 years of Operating Expenses readings, the most recent being $15.5 million for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 14.32% to $15.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $54.3 million, a 7.83% increase, with the full-year FY2025 number at $54.3 million, up 7.83% from a year prior.
  • Operating Expenses hit $15.5 million in Q4 2025 for Lucid Diagnostics, up from $13.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $15.5 million in Q4 2025 to a low of $3.7 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $12.5 million (2023), compared with a mean of $12.0 million.
  • Biggest five-year swings in Operating Expenses: skyrocketed 241.09% in 2022 and later fell 20.12% in 2024.
  • Lucid Diagnostics' Operating Expenses stood at $11.5 million in 2021, then surged by 30.73% to $15.1 million in 2022, then dropped by 17.19% to $12.5 million in 2023, then rose by 8.64% to $13.6 million in 2024, then grew by 14.32% to $15.5 million in 2025.
  • The last three reported values for Operating Expenses were $15.5 million (Q4 2025), $13.0 million (Q3 2025), and $12.5 million (Q2 2025) per Business Quant data.